Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views

NCT01708746 is registered in ClinicalTrials.gov with Verinata Health, Inc. as lead sponsor.

NCT NCT01708746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01708746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
Lead sponsor
Verinata Health, Inc.
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
October 31, 2013
Enrollment
205 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

high risk pregnancy